Connection

Lauge Østergaard to HIV-1

Back to Details
This is a "connection" page, showing publications Lauge Østergaard has written about HIV-1.
Lauge Østergaard
Connection Strength
0.253
HIV-1
  1. Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1-infected individuals. AIDS. 2018 08 24; 32(13):1793-1802.
    View in: PubMed
    Score: 0.063
  2. Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): Immune responses to Vacc-4x regions on p24 and changes in HIV reservoirs. J Infect. 2017 12; 75(6):555-571.
    View in: PubMed
    Score: 0.059
  3. Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 Jun 15; 64(12):1686-1695.
    View in: PubMed
    Score: 0.058
  4. Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations. AIDS. 2017 03 27; 31(6):771-779.
    View in: PubMed
    Score: 0.057
  5. Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):386-393.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.